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Abstract
Abstract: Type 2 diabetes mellitus (T2DM) is a pandemic of great concern among the nutritionrelated non-communicable diseases. Its prevalence is mounting worldwide, particularly in
underserved communities and minority groups. In 2019, 463 million people were diagnosed with
T2DM, a number expected to increase to 578 million by 2030 globally. The prevalence of T2DM
is increasing the mortality rate from cardiovascular complications. The social and health costs of
treating this disease is currently 11% of the global health budget. This project aims to utilize an
evidence-based approach to assess lifestyle interventions' effectiveness at decreasing the
Hemoglobin A1c levels in T2DM individuals after 3 months of lifestyle modifications.

Keywords: type 2 diabetes mellitus, physical activity, lifestyle modifications, prevention, HgA1c
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Diabetes Mellitus in an Underserved Community: A Pilot Project
Diabetes mellitus (DM) is a chronic non-communicable disease affecting carbohydrate
and glucose utilization due to the pancreas' inadequate insulin production. DM develops when
the body cannot regulate glucose balance, leading to complications such as heart disease,
blindness, kidney failure, nerve damage, and lower-extremity amputations (CDC, 2020).
Common causes of mortality among patients with uncontrolled DM include heart disease,
chronic renal failure, and cerebral vascular accidents. As a result of the high morbidity rates,
individuals with DM require more support in managing the disease. There is no cure for DM;
however, DM can be adequately controlled with pharmacological interventions and lifestyle
modifications, such as a healthy diet and aerobic exercise.
Background
According to the Center for Disease Control and Prevention (CDC, 2020), DM is the
seventh leading cause of death in the United States, affecting about 34.2 million people in 2018.
The rate of DM continues to rise both in the United States and globally. The CDC projected an
increase of DM cases by 54% (54.9 million) by 2030. Concern is growing about this disease due
to the rise of cases and possibly earlier onset of type 2 DM (T2DM). T2DM is the most common
type of DM, affecting about 90%-95% of America's total cases (CDC, 2020). T2DM most often
develops in people over age 45. However, more young adults, teenagers, and even grade school
children are developing this disease (CDC, 2020).
The rate of obesity and cardiovascular disease in urban communities has been rising,
increasing the likelihood of T2DM (Animaw & Seyoum, 2017). The clinic used for this project
was a Federally Qualified Health Center (FQHC) clinic located in an urban community in
southern Los Angeles with a significant number of patients at risk of cardiovascular disease from

4
worsening DM. The high rate of DM seen in this community could be attributed to
socioeconomic status, education level, diet, cultural beliefs, treatment compliance, and resources
to encourage optimal health. This project aimed to improve patient outcomes by introducing a
designated follow-up visit to discuss DM management aligned with the American Diabetes
Association’s (ADA) recommended lifestyle modifications.
Literature Review
According to a Diabetes Prevention Program (DPP; National Institute of Diabetes and
Digestive and Kidney Diseases [NIDDK], n.d.) people with prediabetes who take part in a
structured lifestyle change program and lose 5% to 7% of their body weight through healthier
eating and 150 minutes of physical activity per week decrease their risk of developing T2DM by
58%; 71% for people over 60 years of age. Engaging in lifestyle change programs can also
reduce the risk of heart attack and stroke associated with prediabetes and improve overall health
(NIDDK, n.d.). In completing this review, a literature search was conducted using PubMed,
CINAHL Plus with Full Text, and the Cochrane Database, National Institutes of Health using
MESH Type 2 Diabetes Mellitus, Prevention, Lifestyle management, Pharmacotherapy, Costeffectiveness. Four studies provided evidence in support of physical activities in decreasing
HbA1c in T2DM individuals.
Study I: Diabetes Prevention Program (DPP). The DPP examined whether the DPP
Lifestyle Change Program or taking metformin would delay or prevent T2DM. The DPP study
was a randomized, controlled clinical trial conducted at 27 clinical centers around the United
States from 1996 to 2001. The ages of the study participants (N = 3,234) were not specified. The
participants were 55% Caucasian, 45% were minority groups, and at high risk for DM, including
African American, Alaska Native, American Indian, Asian American, Hispanic/Latino, or
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Pacific Islander. Other groups at high risk for T2DM were included, such as people ages 60 years
and older, women with a history of gestational DM, and people with a parent, brother, sister, or
child who had T2DM.
DPP participants were randomly assigned to three groups; the Lifestyle Change Group
provided intensive training. Participants tried to lose 7% of their body weight and maintain that
weight loss by eating less fat and fewer calories and exercising 150 minutes per week. In this
group, researchers met with participants individually at least 16 times in the first 24 weeks, then
every 2 months with at least one phone call between visits. In the metformin group, participants
took 850 mg of metformin twice a day and were given standard advice about diet and physical
activity. Lastly, the control group took a placebo twice a day instead of metformin and were
provided with standard advice about diet and physical activity.
The results of the DDP study were as follows; during the 10-year follow-up period,
participants who took part in the DPP Lifestyle Change Program continued to delay the
development of DM by 34% and developed DM 4 years later compared with participants who
took a placebo. Also, participants from this group ages 60 years and older had a delay in the
development of DM by 49%. In the metformin group, participants who continued with the
medication had a delay in developing DM by 18% and developed DM about 2 years later
compared with participants who took a placebo. In all studied groups, participants improved their
risk factors for cardiovascular diseases, such as high blood pressure and cholesterol. However,
the participants from the DPP Lifestyle Change Program achieved these results while taking less
blood pressure and cholesterol-lowering medications. This study was worthy to practice as Level
II evidence. The study conclusively showed that the DPP Lifestyle Change Program was costeffective, while metformin was a cost-saving form of controlling or preventing T2DM. The DPP
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also showed that people at high risk for T2DM could prevent or delay the disease by losing a
modest amount of weight through lifestyle changes such as dietary changes and increased
physical activity (NIDDK, n.d.).
Study II: Walking prescription of 10 000 steps per day in patients with T2DM mellitus: a
randomized trial in Nigerian general practiced conducted by Fayehun et al. (2018). This study
used a randomized design of two groups: an intervention group with a walking prescription goal
of 10 000 steps per day, and a control group who continued with their typical daily activities.
The study participants were 46 adults with T2DM, aged 18–64 years, diagnosed at least 12
months previously in the clinic. Participants were non-insulin-dependent, on dietary control with
or without oral hypoglycemic agents, and could walk without limitations or pain. Weight, height,
waist and hip circumferences, heart rate, and blood pressure were measured. Glycosylated
hemoglobin (HbA1c) was measured with the Clover A1cTM analyzer (EuroMedix, Leuven,
Belgium), and steps were measured using the waist-mounted Digi-Walker SW-200 electronic
pedometer.
Data included standard deviations, intention-to-treat analysis, and analysis of covariance
(ANCOVA) utilizing SPSS. Results showed an average count of 4,505 steps per day for all
participants, with the average step count in the intervention group in the last 4 weeks of the study
period of 2,913 steps per day (F[2, 37.7] = 18.90, p < 0.001; 95% CI [1274, 4551]). Also, the
mean baseline HbA1c was 6.6% (range 5.3%–9.0%) for all participants. The endline HbA1c was
lower by 0.74% (F = 12.92, p = 0.015; 95% CI [−1.32%, −0.02%] in the intervention compared
with the control groups, after adjusting for baseline HbA1c levels with ANCOVA. Fayehun et
al., (2018) study was worthy to practice as Level II evidence. The study strength provided
evidence regarding the use of a step-count prescription for T2DM. This study's limitations
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included the lack of generalizability of the findings as this was a single-center study with little
ethnic diversity. In addition to a high attrition rate, participants could have been motivated by the
pedometer to increase their step count above their habitual level at baseline. The study's
conclusion noted that motivational strategies and adherence to a 10,000 steps-per-day
prescription, however low, may still have been associated with improved glycemic control in
T2DM.
Study III: The study by García-Molina et al. (2019) used a systematic review and metaanalysis to analyze scientific evidence concerning nutritional intervention in the glycemic control
of T2DM. The research was conducted through PubMed, Scopus, the Cochrane Library, and
Web of Science databases for randomized controlled trials (RCTs) that included lifestyle
intervention (i.e., based on diet, nutritional education, physical activity) in the management of
patients with T2DM. Twenty-eight studies were systematically reviewed with a sample size
ranging from 45 to 1004 adult participants with a mean age ranging between 50 years and 67
years. Participants included non-hospitalized patients or DM patients with complications
including diabetic nephropathy, dementia, cognitive alterations, and mental disorders. Data were
analyzed using several tools, such as the Cochrane risk of bias tool for randomized trials (RoB
2), which was used to assess the included studies' methodological quality. The PRISMA Flow
diagram displayed the selection process of the studies included in the systematic review and
meta-analysis. Lastly, statistical analysis was conducted using Stata Release14 software
(StataCorp., 2015). The result of this study demonstrated that lifestyle interventions significantly
lowered HbA1c levels when compared to the usual care for patients with T2DM. The overall
weighted mean difference (WMD = −0.51 (95% CI [−0.67, −0.35] for post-intervention HbA1c
levels when comparing lifestyle intervention groups to the usual diabetic care controls. The
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WMD of post-intervention HbA1c levels increased with the increase in follow-up duration, from
−0.20 (95% CI [−0.34, −0.05], I2 = 18.5%, p = 0.293) for follow-up of 4–6 months, to − 0.36
(95% CI [−0.56, −0.16], I2 = 73.0%; p = 0.000) when the follow-up length is 7–12 months, and −
0.79 (95% CI [−0.88, − 0.71), I2= 28.8%, p = 0.239) for patients followed up for more than 12
months. However, the most effective increase was seen when combining individualized and
group-based activities (WMD = −0.95; 95% CI [−1.24, −0.66]).
García-Molina et al. (2019) study was worthy to practice as Level I evidence. This
study's strength could be noted in the applicability of the results to improving the management of
T2DM and decreasing other risk factors for cardiovascular diseases. This study's limitations ere
the variability in the applied interventions' contents and the inability to assess pharmacological
treatment compliance due to lack of data. The study's conclusion noted that lifestyle
interventions significantly improve glycemic control of T2DM, mainly when there was a weight
loss greater than 5% of the starting BMI. The improvement of T2DM concerning lifestyle
intervention was significant when the intervention includes diabetes self-management education,
combined individual and group sessions, and/or was over a more extended period.
Study IV: The study by Johansen et al. (2017) aimed to assess whether an intensive
lifestyle intervention would result in equivalent glycemic control compared with standard care
and, secondarily, led to a reduction in glucose-lowering medication in participants with T2DM.
the study's design was a randomized, assessor-blinded, single-center study within Region
Zealand and the Capital Region of Denmark between April 2015 and August 2016. The study's
participants included 98 adult participants with non–insulin-dependent T2DM who were
diagnosed for less than 10 years. Participants were randomly assigned (2:1; stratified by sex) to
the lifestyle group (n = 64) or the standard care group (n = 34).
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Steps and exercise data were collected with a smartwatch (Polar V800) and
measurements (e.g., blood pressure, cholesterol panel, fasting blood work) were performed in
one laboratory. At the same time, biochemical analyses were completed at the central laboratory.
Statistical analysis utilized STATA/IC Release 13.1 (StataCorp, 2013) for intention-to-treat and
repeated-measures mixed linear model (Johansen et al., 2017). All study participants received
standard care, including medical counseling, education in T2DM, and lifestyle advice by the
study nurse at baseline and every 3 months for 12 months. The study included an endocrinologist
who regulated all glucose-lowering, lipid-lowering, and blood pressure-lowering medications
during the study. The endocrinologist was blinded to group allocation and received all clinical
variables from the study nurse. To minimize the risk of bias, prespecified treatment targets and
algorithms for glucose-lowering, lipid-lowering, and blood pressure-lowering medications were
followed by the study endocrinologist to reach standardization across groups.
This study was worthy to practice as Level II evidence. The study's strengths included the
extensive exercise intervention; the blinded, highly standardized algorithm; and the target-driven
approach to regulating glucose-lowering medication in both the lifestyle and standard care
groups. Limitations of the study included adverse events observed in the lifestyle group and the
fact that only participants with T2DM diagnosed for less than 10 years were followed, limiting
the study's generalizability. Lastly, the lifestyle intervention included several lifestyle elements
that presented a challenge in interpreting each intervention's effects. This study concluded that a
lifestyle intervention compared with standard care resulted in a change in glycemic control.
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Table 1
Review of Literature: Evaluation Table
Worth to Practice
Citation: (i.e.,
author(s), date of
publication, &
title)
A
Title: Walking
prescription of 10
000 steps per day in
patients with type 2
diabetes mellitus: A
randomised trial in
Nigerian general
practiced

Major Variables
Studied and
Their
Definitions
IV: Goals to
accumulate
10,000 steps
every day for 10
weeks
DV: HbA1c
endline

Publication date:
January 16, 2018
Authors: Ayorinde
F Fayehun, Olufemi
O Olowookere,
Adetola M
Ogunbode,
Adedotun A
Adetunji & Arinola
Esan
B
Title: Improving
type 2 diabetes
mellitus glycaemic
control through
lifestyle
modification
implementing diet
intervention: a
systematic review
and meta-analysis

IV: Lifestyle
interventions
Diabetes selfmanagement
education
DV: HbA1c
reduction
Decreased in
BMI

Measurement of
Major Variables
Waist- mounted
Digi-Walker SW200 electronic
pedometer
Weight, height,
waist and hip
circumferences,
heart rate, and blood
pressure were
measured.
Glycosylated
hemoglobin
(HbA1c) was
measured with the
Clover A1cTM
analyzer
(EuroMedix,
Leuven, Belgium)
and a questionnaire
administered.
Assessment of
glycemic control,
HbA1c

Data
Analysis
Summary statistics are
reported as mean ±
standard deviation
Sample size was
calculated with a 2sided statistical
superiority design
An intention-to-treat
analysis
Analysis of covariance
(ANCOVA)
A linear regression
model
Analysis performed
using

Cochrane risk of bias
tool for randomized
trials (RoB 2)
PRISMA Flow
diagram
Means and standard
deviations reported by
the authors for HbA1c
levels for the
intervention and
control groups at the

Study Findings
Average step count was 4505 steps
per day for all participants, average
step count in intervention group for
the last 4 weeks of the study period
was 2913 steps per day (95%
confidence interval [CI] = 1,274 to
4,551, F(2, 37.7) = 18.90, p<0.001).
Only 6.1% of the intervention group
participants achieved the 10 000
steps per day goal. The mean
baseline HbA1c was 6.6% (range =
5.3 to 9.0).

Strength of the Evidence (i.e.,
level of evidence + quality [study
strengths and weaknesses])
Feasibility conclusion
RECOMMENDATION
Appraisal: Worth to practice
LOE: 2
Recommendation: A 10,000 step
per day prescription
recommendation was associated
with significant decrease in HbA1c
levels and improved glycemic
control in T2DM individuals.

Endline HbA1c was lower in the
intervention group than in the
control group (mean difference –
0.74%, 95% CI = –1.32 to –0.02, F
= 12.92, P = 0.015) after adjusting
for baseline HbA1c.

Lifestyle interventions significantly
lowered glycosylated hemoglobin
(HbA1c) levels compared to the
usual care for patients with type 2
diabetes mellitus, overall weighted
mean difference, WMD = − 0.51
(−0.67, −0.35). Strategies
combining individualized and
group-based activities were the most
effective, WMD = − 0.95 (− 1.24, −
0.66).

Appraisal: Worth to practice
LOE: I
Recommendation: lifestyle
interventions significantly improve
the glycemic control of type 2
diabetes mellitus and should be
implemented to improving the
management of T2DM, and other
risk factors for cardiovascular
diseases.
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Worth to Practice
Citation: (i.e.,
author(s), date of
publication, &
title)

Major Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Publication date:
November 28, 2019

Data
Analysis

Study Findings

Strength of the Evidence (i.e.,
level of evidence + quality [study
strengths and weaknesses])
Feasibility conclusion
RECOMMENDATION

end of the
intervention/standard
care

Authors: GarcíaMolina, L., LewisMikhael, A.-M.,
Riquelme-Gallego,
B., Cano-Ibáñez, N.,
Oliveras-López, M.J., & BuenoCavanillas, A.

Stratified articles
based on different
characteristics of the
interventions
Stratification based on
characteristics of the
participants including
BMI and the average
duration in years since
the diagnosis of
diabetes.
Sensitivity analyses
excludes low-quality
studies as well as
studies providing
outliers.
Statistical analysis
was conducted using
Stata v.14 software
(Stata Corp., 2015,
College Station, TX,
USA).

C
Title: Effect of an
Intensive Lifestyle
Intervention on
Glycemic Control in
Patients with Type 2
Diabetes A
Randomized
Clinical Trial

IV: Medical
counseling
education in type
2 diabetes
Lifestyle advice
at baseline and
every 3 months
for 12 months
Intensive lifestyle
intervention- 5 to

Steps and exercise
sessions were
objectively
monitored with a
smartwatch (Polar
V800).
Measurements were
performed in 1
laboratory and
biochemical

Intention-to-treat
principle repeatedmeasures mixed linear
model
1-sided tests
Statistical analyses
were performed using
STATA/IC
(StataCorp), version
13.1,

Mean HbA1c level changed from
6.65% to 6.34% in the lifestyle
group and from 6.74% to 6.66% in
the standard care group (mean
between-group difference in change
of −0.26% [95% CI, −0.52% to
−0.01%]), not meeting the criteria
for equivalence (P = .15). Reduction
in glucose-lowering medications
occurred in 47 participants (73.5%)
in the lifestyle group and 9

Appraisal: Worth to practice
LOE: 2
Recommendation: a lifestyle
intervention compared with
standard care resulted in a change
in glycemic control however
further research is needed to assess
superiority, generalizability and
durability of findings.
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Worth to Practice
Citation: (i.e.,
author(s), date of
publication, &
title)
Publication date:
July 10, 2017.
Authors: Mette
Yun Johansen,
Christopher Scott
MacDonald, Katrine
Bagge Hansen, MD,
PhD et al.

Major Variables
Studied and
Their
Definitions
6 weekly aerobic
sessions (duration
30-60 minutes)
with 2 to 3
sessions were
combined with
resistance
training

Measurement of
Major Variables

Data
Analysis

analyses were
completed at the
central laboratory

Study Findings

Strength of the Evidence (i.e.,
level of evidence + quality [study
strengths and weaknesses])
Feasibility conclusion
RECOMMENDATION

participants (26.4%) in the standard
care group (difference, 47.1
percentage points [95% CI, 28.665.3]).

Individualized
dietary plan
Physically active
(≥10 000 steps
per day)
DV: change in
HbA1c level from
baseline to 12month follow-up
reduction in
glucose-lowering
medication from
baseline to 12month follow-up
D
Title: Walking
away from type 2
diabetes: A cluster
randomized
controlled trial.
Publication date:
September 02 2016
Authors: T. Yates
C. L. Edwardson J.
Henson L. J. Gray
N. B. Ashra J.
Troughton K.

IV: 3‐h Walking
Away from Type
2 Diabetes
Mellitus group‐
based structured
educational
programmed
Increase physical
activity by
promoting self‐
regulatory skills
through
pedometer use.

Standardized
booklet detailing
information on Type
2 diabetes mellitus
risk

Generalized
estimating equation
models with an
exchangeable
correlation structure

3‐h Walking Away
from Type 2
Diabetes Mellitus
group‐based
structured
educational
programmed
accelerometer
(GT3X, Actigraph,

Intent to treat
Data processed
through a bespoke
computer programme
(KineSoft version
3.3.76, KineSoft, New
Brunswick, Canada)

Increases in ambulatory activity of
411 steps/day [95% confidence
interval (CI): 117, 704] and selfreported vigorous-intensity physical
activity of 218 metabolic equivalent
min/week (95% CI: 6, 425) at 12
months.

Appraisal: Worth to practice
LOE: 2
Recommendation: Diabetes
prevention guidelines recommend
the use of group-based
interventions
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Worth to Practice
Citation: (i.e.,
author(s), date of
publication, &
title)
Khunti M. J.
Davies

Major Variables
Studied and
Their
Definitions
DV: Physical
activity

Measurement of
Major Variables
Pensacola, FL,
USA).

Biochemical
variables

Data
Analysis

Study Findings

Strength of the Evidence (i.e.,
level of evidence + quality [study
strengths and weaknesses])
Feasibility conclusion
RECOMMENDATION

International Physical
Activity Questionnaire
(IPAQ)
Metabolic equivalents
(METS)

Arterial blood
pressure
measured in the
sitting position.

Oral glucose tolerance
test (OGTT)

Body weight,
Waist
circumference,
Height
E
Title: Effectiveness
of nonpharmacological
strategies in the
management of type
2 diabetes in
primary care: a
protocol for a
systematic review
and network metaanalysis
Publication date:
Janurary 12, 2020
Authors:
Renata Giacomini
Oliveira Ferreira
Leite, Luísa Rocco
Banzato, Julia
Simões Corrêa
Galendi, Adriana
Lucia Mendes,

IV: All nonpharmacological
and patientmediated
strategies.
Nutritional
therapy (dietary
quality or energy
restriction
Physical activity
programmed
Psychological
interventions
Social network
Multidisciplinary
lifestyle
Diabetes selfmanagement
education

N/A

Bayesian hierarchical
model
Surface under the
cumulative ranking
curve (SUCRA).
Grading of
Recommendations
Assessment
Development and
Evaluation (GRADE)
approach.
Calculate numerical
outcome data from
available statistics ex
p values
SDs will be imputed
for outcome value
without measure of
variance
Boxplots

Inadequate glycemic control in
diabetes is most often related to
poor adherence to lifestyle changes
and to the proposed treatment

Appraisal: Worth to practice
LOE: I
Recommendation: to have
individuals have a more active
participation in the control of the
disease, thus achieving higher rates
of glycemic control and fewer
complications associated with
dysglycaemia.
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Worth to Practice
Citation: (i.e.,
author(s), date of
publication, &
title)
Fernanda Bolfi,
Areti Angeliki
Veroniki, Lehana
Thabane, Vania dos
Santos NunesNogueira

Major Variables
Studied and
Their
Definitions

Measurement of
Major Variables

Data
Analysis

DV: glycemic
control (HbA1c
%).

Stata Statistical
Software V.16
(StataCorp LLC)

Anthropometric
measurements
(measured by
weight or waist
circumference
(WC), or body
mass index
(BMI)),

Random effects (RE)
model

Study Findings

Strength of the Evidence (i.e.,
level of evidence + quality [study
strengths and weaknesses])
Feasibility conclusion
RECOMMENDATION

Design-by-treatment
model based on χ 2
test

Quality of life,
patient
satisfaction,
Frequency of
cardiovascular
events and deaths
Number of
patients in each
group with
HbA1c <7
Adverse events
related to nonpharmacological
strategies
Medication
adherence
F
Title: Effects of a
12-week moderateintensity exercise
training on blood
glucose response in

IV: 12-week
moderate exercise
program
Times of exercise
DV: Reduce
blood glucose
level

Graded exercise test
Motorized treadmill
(Track- master 400,
JAS Fitness System,
USA)
One-touch
glucometer

Modified Balke
protocol.
Training protocol
followed the ACSM’s
guidelines “FITT”
Frequency, Intensity,
Time, and Type

The BEBG declined progressively
(b=!1.69, P<.001); while the PEBG
(b=!0.18, P=.08) remained stable
over time during the 12-week
exercise training. Higher BEBG
predicted higher (b=0.53, P<.001)
PEBG. Higher baseline maximum
oxygen uptake (VO2max)

Appraisal:
LOE: 4
Recommendation: preforming
moderate- intensity exercise 1-2
hours post- meal for individuals
taking only oral antidiabetic
medication is safe and beneficial.
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Worth to Practice
Citation: (i.e.,
author(s), date of
publication, &
title)
patients with type 2
diabetes
A prospective
longitudinal study
Publication date:
July 24, 2019
Authors: ShangLin Chiang, PhD,
RN, Margaret
McLean
Heitkemper, PhD,
RN, FAAN, Yi-Jen
Hung, BS, MD,
Wen-Chii Tzeng,
PhD, RN, MeeiShyuan Lee, PhD,
Chia-Huei Lin,
PhD, RN

Major Variables
Studied and
Their
Definitions

Measurement of
Major Variables
(FreeStyle Blood
Glucose Monitoring
System, TheraSense,
USA)
Glucose analyzer
(YSI model 1500
glucose analyzer,
Yellow Springs
Instrument
Company Inc.,
USA)

Data
Analysis
PSS version 16.0
(SPSS Inc., Chicago,
IL)
Descriptive data as
mean/ standard
deviation (SD) and
numbers/percentage
(%)
Univariate analysis
Multivariate analysis
G*Power analysis
(version 3.1)
SPSS version 16.0
(General linear model

Study Findings
contributed to a larger magnitude of
EIGR; higher HgbA1c and BEBG
predicted higher EIGR (b = 0.27, P
= .02; b = 0.45, P < .001); afternoon
or evening exercise predicted lower
(b = -13.2, P = .04; b = -5.96, P =
.005) EIGR than did morning
exercise.

Strength of the Evidence (i.e.,
level of evidence + quality [study
strengths and weaknesses])
Feasibility conclusion
RECOMMENDATION
Overall moderate high intensity
exercise produce improvement in
metabolic control.
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Methods
Design
This EBP project was a nurse practitioner (NP) driven educational intervention utilizing
the ADA (2019) guideline, "Prevention or Delay of Type 2 Diabetes Standards of Medical Care
in Diabetes- 2021." This 24-week evidence-based practice (EBP) project utilized pre-post
intervention data. The goal was to improve HgA1c levels among pre-diabetic and T2DM
patients. The population for this project included patients diagnosed with T2DM with HbA1c
6.5% or greater. The intervention included education on an exercise plan for a minimum of 150
minutes a week and the ADA diet. There was also an emphasis on low carbohydrate and low
sugar intake to further decrease the HA1c level by 15% or greater in a period of 3 months. The
project was approved and received exempt status from the University of San Diego's Institutional
Review Board (IRB)
The Stetler (2001) Model of Evidence-Based Practice was utilized for the implementation
of this EBP project to evaluate the effectiveness of the interventions. The Stetler model
facilitates the implementation of research findings into clinical practice. This model is known as
the practitioner-oriented model geared to advanced practitioners, such as clinical nurse
specialists (CNS), NPs, and Doctor of Nursing Practice (DNP)-prepared nurses (Melnyk &
Fineout-Overholt, 2019). The Stetler model enables practitioners to assess how research findings
and other pertinent evidence are implemented in clinical practice by a series of steps (Stetler,
2001). This model examines the evidence to create change that fosters patient-centered care,
including individualized, patient-focused care. The Stetler model was selected for this project to
encourage critical thinking and research finding integration, promote EBP practice, and help
lessen errors in medical decision-making (Stetler, 2001). The Stetler model includes five phases:
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preparation, validation, comparative evaluation/decision making, translation/application, and
evaluation.
Setting and Sample
Study participants were recruited from a FQHC community health clinic located in
Southern California. This organization offers comprehensive medical services, from routine
preventive care to the management of chronic diseases such as DM and high blood pressure. This
organization primarily serves all patients regardless of immigration status and socioeconomic
status, with a high Hispanic population. The sample for this project was composed of 20
Hispanic patients, aged 18 to 73 years diagnosed with T2DM. Inclusion criteria: 18 years old and
older diagnosed with prediabetes or noninsulin DM in the FQHC community health clinic.
Exclusion criteria: patients less than 18 years of age and patients diagnosed with insulindependent DM.
Intervention
The intervention included the introduction of a designated follow-up visit to address DM
management with the recommended lifestyle modifications. This NP-driven education utilized
the ADA (2021) guideline "Prevention or Delay of Type 2 Diabetes Standards of Medical Care
in Diabetes – 2021." Patients diagnosed with prediabetes or T2DM received designated followup appointments for non-pharmacological lifestyle modification interventions to improve
hemoglobin A1C. This educational intervention was done in correlation with the standards of
care listed by the ADA. The ADA Standards of Medical Care in Diabetes-2021 patient education
include: (a) engaging in a minimum of 150 minutes of exercise per week; (b) weight loss goal of
7% or 1-2 lbs. per week; and (c) diet education on low carb intake and calorie counting. When
clinically appropriate, patients were instructed to subtract 500-1000 calories/day depending on
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initial body weight and their current eating habits. All participating patients were provided with a
log to document their weekly activity. These activity logs were assessed during their routine
follow-up visits.
Data
Demographic data included: (a) age; (b) gender; and (c) race/ethnicity. Data were
collected from the electronic medical records (EMR). Additionally, the patient's exercise and diet
surveys were collected to assess their activity level and dietary habits. Pre- and post-intervention
surveys were obtained. The 6-question survey that was used to assess the lifestyle modification
practices among the 20 patients can be seen in Table 2.
Table 2
Six Question Survey
Survey Question
1. Do you exercise weekly? if so, how many minutes per week do you exercise?
2. What type of exercise do you do? (e.g., jogging, walking, cycling, etc.)
3. Do you know how many calories per day you should eat?
4. Do you know how to count calories?
5. Do you know which type of diet you should follow?
6. Which foods should you avoid or be limited in your daily diet?

Procedures
The surveys were given to the patients to be completed before the intervention, at 3
months, and 6 months post-intervention during their routine follow-up. In addition, to the survey,
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additional data were collected to assess the patients' outcomes: (a) BMI; (c) HgA1c, (c) activity
levels; and (d) adherence to the ADA diet.
Data Collection
The data for this EBP project were deidentified for the retrospective-prospective chart
review. The information was collected from January 2021 to June 2021 to have enough time to
see a change in the HgA1c. Data collected included: demographics, weight, medications, and
HgA1c level. These data served as the baseline for comparison. All collected data were
encrypted and stored in a password-protected laptop using a protected server in the facility.
Survey data were collected and recorded using Microsoft Excel.
Data Analysis
All data analyses were performed using the Intellectus Statistics software (α ≤ .05 for
statistical significance). Descriptive statistics were used to analyze participant demographics
using frequencies and percentages, and continuous data were analyzed using means and standard
deviations. The primary outcome of improving HgA1c levels among pre-diabetic and T2DM
patients was analyzed by a repeated-measures analysis of variance (ANOVA) and descriptive
statistics. The secondary outcome measuring the difference in pre and post intervention BMI was
analyzed using a two-tailed paired sample t-test.
Results
In total, 20 Hispanic patients diagnosed with T2DM participated in the project. The group
also include one nurse practitioner. Most participants (n = 16, 80%) were females aged 56 years
and older.
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Figure 1
Age of Participants
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The results of the ANOVA assessing the primary outcome of improving HgA1c levels
among pre-diabetic and T2DM patients after education on lifestyle modifications was not
significant (F[2, 38] = 0.49, p = .618), indicating the values of HgA1c at Pre, 3-, and 6-months
post-intervention were all similar.
Figure 2
Q-Q Scatterplot for Normality of the Residuals for the Regression Model.

Table 3 presents the ANOVA results. Additional information about the means of the
within-subjects factor are presented in Table 3 and Figure 3.
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Table 3
Repeated Measures ANOVA Results
Source

df

SS

MS

F

p

ηp2

Within
Subjects
Within Factor
Residuals

2
38

0.82
31.82

0.41
0.84

0.49

.618

0.03

Table 4
Means Table for Within-Subject Variables
Variable
HgA1cPre
HgA1c3Mo
HgA1c6Mo
Note. n = 20.

M
7.58
7.86
7.70

SD
0.84
1.45
1.46

Figure 3
Within-Subject Variable Means

The descriptive statistics showed (n = 13, 65%) that participants decreased their A1c
levels during the project period. In addition, the two-tailed independent samples t-test was
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significant (t[18]) = -2.28, p = .035). This outcome indicates the mean between the pre and post
HgA1c groups was significantly different between participants who gained weight and those who
lost weight.
Table 5
Two-Tailed Independent Samples t-Test for A1cPrePost by WtUpDown
Pre
Variable
M
SD
A1cPrePost
-0.85
1.53
Note. N = 20. d represents Cohen's d.

Post
M
0.36

SD
0.85

t
-2.28

p
.035

d
0.98

Figure 4
The Mean of A1cPrePost by Levels of WtUpDown with 95.00% CI Error Bars

The secondary outcome measure of the difference in pre and post-intervention BMI was
significant (t[19] = 2.32, p = .032), which showed a difference in the mean of pre-BMI the mean
of post-BMI was significantly different from zero. The two-tailed paired samples t-test suggested
that pre-BMI mean was significantly higher than the post mean. Before the intervention, 19 or 20
participants did not engage in 150 minutes of exercise a week; however, at 6 months postintervention, the number of participants rose from 1 to 5 of 20 participants and made a change in
their lifestyle. This change could also be noted in the number of reported weight loss (n = 12,
60%) between pre and post-intervention by participants. Pre-intervention, none of the
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participants followed the ADA diet of low carb intake and calorie counting. At the end of the
project, 14 of 20 participants were adhering to the ADA diet (Table 6, bar plot of means in
Figure 5). Frequencies and percentages are presented in Table 7.
Table 6
Two-Tailed Paired Samples t-Test for the Difference Between BMIPre and BMIPost
BMIPre

BMIPost

M
SD
M
SD
t
p
30.70
4.77
29.83
5.37
2.32
.032
Note. N = 20. Degrees of Freedom for the t-statistic = 19. d represents Cohen's d.

Figure 5
The Means of BMIPre and BMIPost with 95.00% CI Error Bars

d
0.52
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Table 7
Frequency Table for Nominal Variables
Variable

n

%

16
4

80
20

20

100

1
19

5
95

5
15

25
75

20

100

6
14

30
70

8
12

40
60

7
13

35
65

Gender
Female
Male
Race
Hispanic
ActivityLevelPre
Yes
No
ActivityLevelPost
Yes
No
ADADietPre
No
ADADietPost
Yes
No
WtUpDown
Up
Down
A1cUpDown
Up
Down
Note. Due to rounding errors, percentages may not equal 100%.

Discussion
The DPP states that people with prediabetes who take part in a structured lifestyle change
program, lose 5% to 7% of their body weight through healthier eating, and include 150 minutes
of physical activity per week will minimize their risk of developing T2DM by 58% in those 59
years of age and younger; that number rises to 71% for people over 60 years of age. This EBP
project was designed to increase awareness of the importance of prescribing lifestyle
interventions in the management of prediabetes and T2DM. Despite the small participant sample
size of (n = 20), this NP-driven educational intervention on lifestyle modifications in DM
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management demonstrated an overall decrease in group HgA1c levels between participants that
lost weight and those that gained weight.
The average pre-intervention A1c level for those who gained weight was 7.75, and for
those who lost weight 7.46, there was a 0.29 difference between both groups. After 3 months, the
post-intervention A1c level in weight gainers increased from 7.75 to 8.46. In comparison, A1c
levels in those that lost weight decreased from 7.46 to 7.44. at 6 months, weight gainers' A1c
levels again increased from 8.46 to 8.6, while weight losers' A1c decreased from 7.44 to 7.10.
Although only a small decrease in A1c level was observed, it is important to note that individuals
who lost weight went from a BMI level classified as obesity to overweight with a reported
increase in adherence to an ADA diet. Although the education on lifestyle modification
interventions was not statically significant (p = .618), the findings indicated clinical importance
and suggested that small improvements can be made in health promotion, disease progression,
and prevention.
Limitations of this project that should be considered include sample size providing
inadequate power to demonstrate statically significant results. In addition, data were collected
during the holiday seasons of Thanksgiving and Christmas. In December 2021, an online survey
conducted by the ADA and the American Heart Association revealed that 73% of people with
DM had complete control of dietary choices during a normal week; however, 52% reported less
control during holiday weeks due to the many temptations and stress around the festive times. In
addition to the holiday season, the participants in this project were affected by the global
COVID-19 pandemic guidelines; lockdown and social distancing may have limited patients'
access to exercise environments and healthier food choices.
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The St John's Community Health organization serves an ethnically- and
socioeconomically disadvantaged population across urban and suburban settings with an
insurance mix of 80% uninsured and 20% private or public (Medicaid) insurance. Literature has
shown that increased prevalence of DM is seen more in urban areas whose residents are noted to
be obese, overweight, or have other underlying conditions such as hypertension. As this
organization primarily serves a population commonly affected with DM, consideration must be
made regarding patients' ability to access healthier foods and engage in physical activities.
Implications for Practice
The literature review supported the use of lifestyle modifications, physical activity, low
carb diet, and patient education to manage T2DM to prevent or delay the progression of this
chronic disease. Lifestyle modifications can avert disease complications; therefore, providers
should employ these interventions in practice. More research is needed to increase patient
adherence to these lifestyle modifications.
Conclusion
Lifestyle modifications are considered a cornerstone in managing T2DM. It improves
blood glucose control, decreases cardiovascular disease, and improves general well-being.
Lifestyle modifications play an enormous role in preventing chronic complications of DM and
cardiovascular disease. The results of this EBP project demonstrated a positive correlation to
favor lifestyle modifications with an emphasis on increased physical activity and dieting. There
were positive results identifying a decrease in hemoglobin A1c levels, weight, and improvement
in overall patient well-being. The Level I and II evidence of the reviewed studies provided
support for prescribing physical activities in the treatment regimen of T2DM.
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